Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1Lymphoid 1

Conditions

Ovarian Neoplasms 2Colorectal Neoplasms 2Breast Neoplasms 2Tuberous Sclerosis 1Pyloric Stenosis, Hypertrophic 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Lymphangioleiomyomatosis 1Histiocytosis, Non-Langerhans-Cell 1Histiocytosis, Langerhans-Cell 1HER2-positive Breast Cancer 1Castleman Disease 1Anatomic Stage II Breast Cancer AJCC v8 1

Interventions

X-Rays 5Phantoms, Imaging 5Nuclear Medicine Department, Hospital 5Magnetic Resonance Spectroscopy 5Specimen Handling 4Biopsy 4ulixertinib 2tipifarnib 2selpercatinib 2larotrectinib 2ivosidenib 2erdafitinib 2ensartinib 2trametinib 1tazemetostat 1palbociclib 1olaparib 1dabrafenib 1Vemurafenib 1Pharmacogenomic Variants 1LY3023414 1Genetic Testing 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Histiocytosis, Langerhans-Cell × Genetic Testing × 30 days × Clear all
NCT05028621 2026-05-07

Molecular Basis of Langerhans and Non-Langerhans Cell Histiocytic Neoplasms and Castleman Disease

Case Comprehensive Cancer Center

Phase NA Suspended
135 enrolled
LymphoidMyeloid

Castleman Disease, Histiocytosis, Langerhans-Cell, Histiocytosis, Non-Langerhans-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡